Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barrio

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Revista Espanola De Enfermedades Digestivas|April 6, 2010
A retrospective study of pediatric endoscopy as performed in an adult endoscopy unitL Julián-Gómez, J Barrio, R Izquierdo, et al.
Revista Espanola De Enfermedades Digestivas|December 7, 2007
[Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy's lesion]A Ibáñez, E Castro, E Fernández, et al.
Infection Control and Hospital Epidemiology|May 1, 1996
Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial Infections Prevalence Study in SpainJ Vaqué, J Rosselló, A Trilla, et al.
Digestive Diseases and Sciences|October 16, 2013
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infectionJ P Gisbert, A Perez-Aisa, L Rodrigo, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2016
The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitisJ Rodríguez-Sánchez, J Barrio-Andrés, O Nantes Castillejo, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2015
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON studyJ Molina-Infante, A J Lucendo, T Angueira, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2015
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatmentsJ P Gisbert, M Romano, A G Gravina, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Revista Espanola De Enfermedades Digestivas|April 6, 2010
A retrospective study of pediatric endoscopy as performed in an adult endoscopy unitL Julián-Gómez, J Barrio, R Izquierdo, et al.
Revista Espanola De Enfermedades Digestivas|December 7, 2007
[Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy's lesion]A Ibáñez, E Castro, E Fernández, et al.
Infection Control and Hospital Epidemiology|May 1, 1996
Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial Infections Prevalence Study in SpainJ Vaqué, J Rosselló, A Trilla, et al.
Digestive Diseases and Sciences|October 16, 2013
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infectionJ P Gisbert, A Perez-Aisa, L Rodrigo, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2016
The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitisJ Rodríguez-Sánchez, J Barrio-Andrés, O Nantes Castillejo, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2015
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON studyJ Molina-Infante, A J Lucendo, T Angueira, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2015
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatmentsJ P Gisbert, M Romano, A G Gravina, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
Pageof 18